Furthermore, a RCT (NCT03357380) is currently comparing the change in early stages of scar tissue as well as fat deposition in the liver, as detected by magnetic resonance imaging scans, in patients treated with semaglutide or placebo for 72 weeks
If GLP-1s are affecting different parts of the body, you might wonder what else it might be affecting
Always speak to a licensed provider to determine whether GLP-1 therapy is medically appropriate for you
E.NdubuizuN.et al (2018)
The capsules contain a 1,440mg proprietary "GLP-1 Activation Blend" that includes acacia hydrolysate, berberine root extract, matcha leaf powder, lemon bioflavonoids, hesperidin, honeysuckle, yerba mate, and eggplant extract
Using HSA funds for a non-qualified expense triggers two penalties